Comparison of the Pharmacokinetics of Subcutaneous Ustekinumab between Chinese and Non-Chinese Healt...
Comparison of the Pharmacokinetics of Subcutaneous Ustekinumab between Chinese and Non-Chinese Healthy Male Subjects across Two Phase 1 Studies
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing AG
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing AG
Subjects
More information
Scope and Contents
Contents
Background and Objective
Ustekinumab, a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody against interleukin-12/23p40, has been reported to be significantly efficacious in treating patients with moderate-to-severe plaque psoriasis. Although the efficacy and safety of ustekinumab have been previously studied in Asian patients with psoria...
Alternative Titles
Full title
Comparison of the Pharmacokinetics of Subcutaneous Ustekinumab between Chinese and Non-Chinese Healthy Male Subjects across Two Phase 1 Studies
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1462765768
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1462765768
Other Identifiers
ISSN
1173-2563
E-ISSN
1179-1918
DOI
10.1007/s40261-013-0072-2
